eISSN: 1731-2531
ISSN: 1642-5758
Anaesthesiology Intensive Therapy
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
SCImago Journal & Country Rank

 
3/2022
vol. 54
 
Share:
Share:
more
 
 
abstract:
Original paper

Mid-regional pro-adrenomedullin as a predictor of in-hospital mortality in adult patients with COVID-19: a single-centre prospective study

Dmitry Popov
1
,
Ulyana Borovkova
1
,
Mikhail Rybka
1
,
Tatiana Ramnyonok
1
,
Elena Golukhova
1

1.
A.N. Bakulev National Medical Research Center of Cardiovascular Surgery, Moscow, Russia
Anaesthesiol Intensive Ther 2022; 54, 3: 242–246
Online publish date: 2022/09/02
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Background
To determine the predictive value of mid-regional pro-adrenomedullin (MR-proADM) compared to routine clinical and laboratory parameters in patients with COVID-19.

Methods
A total of 135 adult patients hospitalized with COVID-19 were included in a prospective single-centre study. In addition to routine parameters, the levels of MR-proADM in blood plasma were measured on the day of hospitalization. The patients were divided into 2 groups: those who survived and were discharged (n = 115, 85%) and those who did not survive (n = 20, 15%). Data are presented as median and interquartile range.

Results
The non-survivors had a statistically significantly greater age (73.4 [63.5–84.8] vs. 62.2 [50.3–71.4] years, P = 0.001), a lower level of haemoglobin oxygen saturation (91 [87–92] vs. 92 [92–93]%, P < 0.001), lower lymphocyte level (13 [7–30] vs. 21 [15–27]%, P = 0.03), higher lactate dehydrogenase (338 [273–480] vs. 280 [233–383] EU L–1, P = 0.04) and aspartate aminotransferase levels (49 [28–72] vs. 33 [23–47] EU L–1, P = 0.03), a higher National Early Warning (NEWS) score (7 [7– 8] vs. 6 [5–7] points, P < 0.001), and higher procalcitonin (0.16 [0.11–0.32] vs. 0.1 [0.07–0.18] ng mL–1, P = 0.006) and MR-proADM levels (1.288 [0.886–1.847] vs. 0.769 [0.6–0.955] nmol L–1, P < 0.001). MR-proADM had the highest predictive value for death during hospital stay (cut-off: 0.895 nmol L–1, AUC ROC 0.78 [95% CI: 0.66–0.90], sensitivity 75%, specificity 69%, OR 6.58 [95% CI: 2.22–19.51]).

Conclusions
Compared with other indicators, MR-proADM has the highest predictive value for in-hospital mortality in patients with COVID-19.

keywords:

biomarkers, predictors, COVID-19, mortality, pro-adrenomedullin

Quick links
© 2022 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.